AR229342A1 - Procedimiento para obtener derivados de(5-tetrazolilalquilenoxi)-carboestirilo o 3,4-dihidrocarboestirilo y procedimiento para preparar 5-haloalquilen-tetrazol de aplicacion exclusiva como reactivo en dicho procedimiento - Google Patents
Procedimiento para obtener derivados de(5-tetrazolilalquilenoxi)-carboestirilo o 3,4-dihidrocarboestirilo y procedimiento para preparar 5-haloalquilen-tetrazol de aplicacion exclusiva como reactivo en dicho procedimientoInfo
- Publication number
- AR229342A1 AR229342A1 AR277883A AR27788379A AR229342A1 AR 229342 A1 AR229342 A1 AR 229342A1 AR 277883 A AR277883 A AR 277883A AR 27788379 A AR27788379 A AR 27788379A AR 229342 A1 AR229342 A1 AR 229342A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- tetrazolylalkyleneoxi
- dihydrocarbonsyrile
- carbostyrile
- haloalkylene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10786978A JPS5535019A (en) | 1978-09-01 | 1978-09-01 | Carbostyryl derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
AR229342A1 true AR229342A1 (es) | 1983-07-29 |
Family
ID=14470137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR277883A AR229342A1 (es) | 1978-09-01 | 1979-08-29 | Procedimiento para obtener derivados de(5-tetrazolilalquilenoxi)-carboestirilo o 3,4-dihidrocarboestirilo y procedimiento para preparar 5-haloalquilen-tetrazol de aplicacion exclusiva como reactivo en dicho procedimiento |
Country Status (23)
Country | Link |
---|---|
US (1) | US4277479A (de) |
JP (1) | JPS5535019A (de) |
AR (1) | AR229342A1 (de) |
AT (1) | AT364363B (de) |
AU (1) | AU538410B2 (de) |
BE (1) | BE878548A (de) |
CA (1) | CA1139761A (de) |
CH (1) | CH641799A5 (de) |
DE (1) | DE2934747A1 (de) |
DK (1) | DK158788C (de) |
ES (1) | ES483792A1 (de) |
FI (1) | FI68398C (de) |
FR (1) | FR2434809A1 (de) |
GB (1) | GB2033893B (de) |
IT (1) | IT1119929B (de) |
MX (1) | MX6749E (de) |
NL (1) | NL183888C (de) |
NO (1) | NO153177C (de) |
PH (1) | PH18452A (de) |
PT (1) | PT70136A (de) |
SE (1) | SE432252B (de) |
SU (1) | SU1064868A3 (de) |
ZA (1) | ZA794627B (de) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57156469A (en) * | 1981-03-19 | 1982-09-27 | Otsuka Pharmaceut Co Ltd | Preparation of tetrazole derivative |
JPS57183761A (en) * | 1981-04-30 | 1982-11-12 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
JPS5859980A (ja) * | 1981-10-05 | 1983-04-09 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
JPS5877880A (ja) * | 1981-11-05 | 1983-05-11 | Otsuka Pharmaceut Co Ltd | テトラゾ−ル誘導体 |
DE3225169A1 (de) * | 1982-07-06 | 1984-01-12 | Basf Ag, 6700 Ludwigshafen | Chinolinderivate, verfahren zu ihrer herstellung, diese enthaltende mikrobizide und ihre verwendung zur bekaempfung von pilzen |
US4803162A (en) * | 1984-05-15 | 1989-02-07 | Fluorodiagnostic Limited Partners | Composition, article and process for detecting a microorganism |
PT80533B (en) * | 1984-05-29 | 1987-04-06 | Pfizer | Process for preparing quinolone inotropic agents |
GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
JPH0681752B2 (ja) * | 1986-04-02 | 1994-10-19 | 大塚製薬株式会社 | カルボスチリル誘導体 |
DK167187A (da) | 1986-04-02 | 1987-10-03 | Otsuka Pharma Co Ltd | Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse |
JPH0681727B2 (ja) * | 1986-04-02 | 1994-10-19 | 大塚製薬株式会社 | 血小板粘着抑制剤 |
KR940000785B1 (ko) * | 1986-04-02 | 1994-01-31 | 오오쓰까세이야꾸 가부시끼가이샤 | 카르보스티릴 유도체 및 그의 염의 제조 방법 |
JP2753622B2 (ja) | 1988-05-02 | 1998-05-20 | 大塚製薬株式会社 | カルボスチリル誘導体 |
US5064837A (en) * | 1989-11-13 | 1991-11-12 | Schering Corporation | 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions |
ES2067920T3 (es) * | 1990-01-08 | 1995-04-01 | Otsuka Pharma Co Ltd | Tonico para el cabello y composicion acondicionadora. |
TW201305B (de) * | 1991-04-03 | 1993-03-01 | Otsuka Pharma Co Ltd | |
WO1993004042A1 (fr) * | 1991-08-23 | 1993-03-04 | Otsuka Pharmaceutical Co., Ltd. | Derive de carbostyrile et antiagregant plaquettaire |
JPH0776521A (ja) * | 1993-09-07 | 1995-03-20 | Otsuka Pharmaceut Co Ltd | 気道炎症抑制剤 |
US6187790B1 (en) | 1999-03-04 | 2001-02-13 | Neal R. Cutler | Use of cilostazol for treatment of sexual dysfunction |
US20030045547A1 (en) | 2001-05-02 | 2003-03-06 | Shinji Aki | Process for producing carbostyril derivatives |
JP4060523B2 (ja) * | 1999-11-24 | 2008-03-12 | 大塚製薬株式会社 | カルボスチリル誘導体の製造法 |
US6825214B2 (en) * | 2000-08-14 | 2004-11-30 | Teva Pharmaceutical Industries, Ltd. | Substantially pure cilostazol and processes for making same |
AU2001250892A1 (en) * | 2000-03-20 | 2001-10-03 | Teva Pharmaceutical Industries Ltd. | Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n-(4-methoxyphenyl)-3-chloropropionamide |
US6515128B2 (en) | 2000-03-20 | 2003-02-04 | Teva Pharmaceutical Industries Ltd. | Processes for preparing cilostazol |
SK2992003A3 (en) * | 2000-08-14 | 2003-10-07 | Teva Pharma | Processes for preparing cilostazol |
US6458804B1 (en) | 2001-01-26 | 2002-10-01 | R.T. Alamo Venturesi, Llc | Methods for the treatment of central nervous system disorders in certain patient groups |
US6451813B1 (en) | 2001-01-26 | 2002-09-17 | R. T. Alamo Ventures I, Llc | Treatment of gastroparesis in certain patient groups |
US20050101631A1 (en) * | 2002-08-01 | 2005-05-12 | Otsuka Pharmaceuticals Company | Process for producing carbostyril derivatives |
US7399864B2 (en) * | 2001-05-02 | 2008-07-15 | Otsuka Pharmaceutical Co., Ltd. | Process for producing carbostyril derivatives |
JP2003063965A (ja) * | 2001-06-13 | 2003-03-05 | Otsuka Pharmaceut Factory Inc | 注射用シロスタゾール水性製剤 |
US6573382B2 (en) * | 2001-06-29 | 2003-06-03 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US6596871B2 (en) * | 2001-06-29 | 2003-07-22 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US6657061B2 (en) * | 2001-06-29 | 2003-12-02 | Grayson Walker Stowell | Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US6388080B1 (en) | 2001-06-29 | 2002-05-14 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US6531603B1 (en) * | 2001-06-29 | 2003-03-11 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
AU2002322456A1 (en) * | 2001-06-29 | 2003-03-03 | Aaipharma, Inc. | Polymorphic forms of 6-(4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy)-3, 4-dihydro-2(1h)-quinolinone |
WO2003002121A1 (en) * | 2001-06-29 | 2003-01-09 | Aaipharma, Inc. | Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone |
US6660864B2 (en) * | 2001-06-29 | 2003-12-09 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
WO2004024716A1 (ja) * | 2002-09-10 | 2004-03-25 | Otsuka Pharmaceutical Co., Ltd. | シロスタゾールの製造法 |
US6743806B2 (en) * | 2002-10-23 | 2004-06-01 | Otsuka Pharmaceutical Company, Limited | Active oxygen scavenger |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
TWI323660B (en) | 2003-02-25 | 2010-04-21 | Otsuka Pharma Co Ltd | Pten inhibitor or maxi-k channels opener |
ITMI20031670A1 (it) * | 2003-08-26 | 2005-02-27 | Dinamite Dipharma S P A In Forma A Bbreviata Diph | Processo per la preparazione di cilostazolo e di suoi intermedi. |
US7524960B2 (en) * | 2004-03-16 | 2009-04-28 | Chemagis Ltd. | Highly pure cilostazol and an improved process for obtaining same |
US20050255155A1 (en) * | 2004-05-11 | 2005-11-17 | Glenmark Pharmaceuticals Limited | Modified release cilostazol compositions |
US20080206348A1 (en) * | 2004-09-17 | 2008-08-28 | Deepak Murpani | Cilostazol-Containing Pharmaceutical Composition Based On Particles Of Less Than 50 Micrometers |
CN100462360C (zh) * | 2005-08-15 | 2009-02-18 | 上海立科药物化学有限公司 | N-环己基-5-(4-氯丁基)-1h-四氮唑的合成方法 |
PL1942895T3 (pl) | 2005-09-15 | 2012-07-31 | Otsuka Pharma Co Ltd | Lek złożony zawierający probukol i pochodną tetrazoliloalkoksydihydrokarbostyrylu o działaniu hamującym nadtlenek |
US20070105898A1 (en) * | 2005-11-09 | 2007-05-10 | Apotex Pharmachem Inc. | Process for the production of cilostazol |
AR065588A1 (es) | 2007-03-09 | 2009-06-17 | Otsuka Pharma Co Ltd | Un medicamento para tratar enfermedad pulmonar obstructiva cronica |
TW200848041A (en) | 2007-03-30 | 2008-12-16 | Otsuka Pharma Co Ltd | A medicament for treating schizophrenia comprising cilostazol |
US8349817B2 (en) * | 2007-04-25 | 2013-01-08 | Concert Pharmaceuticals, Inc. | Analogues of cilostazol |
EP2527336A1 (de) | 2007-04-25 | 2012-11-28 | Concert Pharmaceuticals Inc. | Deuterium Analoga von Cilostazol |
PT2157973E (pt) | 2007-05-22 | 2015-10-14 | Otsuka Pharma Co Ltd | Medicamento compreendendo um derivado de carbostirilo e donepezilo para o tratamento da doença de alzheimer |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
CA2688161C (en) | 2007-06-04 | 2020-10-20 | Kunwar Shailubhai | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
ES2522968T3 (es) | 2008-06-04 | 2014-11-19 | Synergy Pharmaceuticals Inc. | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
EP2194048A1 (de) * | 2008-12-02 | 2010-06-09 | Dirk Sartor | Nitratester zur Behandlung von vaskularen und metabolischen Krankheiten |
CN102933205B (zh) | 2010-04-28 | 2014-08-13 | 诺弗米克斯有限公司 | 西洛他唑共晶和组合物 |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CN108676076A (zh) | 2011-03-01 | 2018-10-19 | 辛纳吉制药公司 | 制备鸟苷酸环化酶c激动剂的方法 |
WO2014131024A2 (en) | 2013-02-25 | 2014-08-28 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
EP2970384A1 (de) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonisten der guanylatcyclase und deren verwendungen |
US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法 |
MX2016001714A (es) | 2013-08-09 | 2016-10-03 | Ardelyx Inc | Compuestos y metodos para inhibir el transporte de fosfato. |
WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2470084A (en) * | 1945-09-25 | 1949-05-17 | Bilhuber Inc E | Substituted alpha-halogen alkyl tetrazoles and process for obtaining the same |
US2470085A (en) * | 1947-03-07 | 1949-05-17 | Bilhuber Inc E | Substituted amino alkyl tetrazoles |
AR207554A1 (es) * | 1972-12-02 | 1976-10-15 | Otsuka Pharma Co Ltd | Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2) |
JPS5310986B2 (de) * | 1974-02-05 | 1978-04-18 | ||
JPS5310989B2 (de) * | 1974-04-25 | 1978-04-18 | ||
FI59246C (fi) * | 1974-06-24 | 1981-07-10 | Otsuka Pharma Co Ltd | Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin |
FI58329C (fi) * | 1974-11-08 | 1981-01-12 | Otsuka Pharma Co Ltd | Foerfarande foer framstaellning av i 8-staellning substituerade 5-(3'-alkylamino-2'-hydroxi)propoxi-3,4-dihydrokarbostyrilderivat |
US4129565A (en) * | 1975-07-11 | 1978-12-12 | Nisshin Flour Milling Co., Ltd. | Isocarbostyril derivatives |
US4210753A (en) * | 1976-03-17 | 1980-07-01 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril compounds |
JPS52116482A (en) * | 1976-03-24 | 1977-09-29 | Otsuka Pharmaceut Co Ltd | Carbostyril derivatives and its preparation |
JPS5430183A (en) * | 1977-08-10 | 1979-03-06 | Otsuka Pharmaceut Co Ltd | 3,4-dihydrocarbostyril derivative |
-
1978
- 1978-09-01 JP JP10786978A patent/JPS5535019A/ja active Granted
-
1979
- 1979-08-22 CA CA000334272A patent/CA1139761A/en not_active Expired
- 1979-08-28 DE DE19792934747 patent/DE2934747A1/de active Granted
- 1979-08-29 US US06/070,710 patent/US4277479A/en not_active Expired - Lifetime
- 1979-08-29 AR AR277883A patent/AR229342A1/es active
- 1979-08-29 AU AU50397/79A patent/AU538410B2/en not_active Expired
- 1979-08-29 PH PH22976A patent/PH18452A/en unknown
- 1979-08-30 DK DK363179A patent/DK158788C/da active
- 1979-08-30 FI FI792699A patent/FI68398C/fi not_active IP Right Cessation
- 1979-08-30 SU SU792804457A patent/SU1064868A3/ru active
- 1979-08-30 NL NLAANVRAGE7906523,A patent/NL183888C/xx not_active IP Right Cessation
- 1979-08-31 ZA ZA00794627A patent/ZA794627B/xx unknown
- 1979-08-31 PT PT70136A patent/PT70136A/pt unknown
- 1979-08-31 ES ES483792A patent/ES483792A1/es not_active Expired
- 1979-08-31 SE SE7907236A patent/SE432252B/sv not_active IP Right Cessation
- 1979-08-31 CH CH792079A patent/CH641799A5/de not_active IP Right Cessation
- 1979-08-31 NO NO792829A patent/NO153177C/no unknown
- 1979-08-31 MX MX798357U patent/MX6749E/es unknown
- 1979-08-31 IT IT68748/79A patent/IT1119929B/it active
- 1979-08-31 FR FR7921869A patent/FR2434809A1/fr active Granted
- 1979-08-31 BE BE0/196976A patent/BE878548A/xx not_active IP Right Cessation
- 1979-09-03 AT AT0584579A patent/AT364363B/de not_active IP Right Cessation
- 1979-09-03 GB GB7930520A patent/GB2033893B/en not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR229342A1 (es) | Procedimiento para obtener derivados de(5-tetrazolilalquilenoxi)-carboestirilo o 3,4-dihidrocarboestirilo y procedimiento para preparar 5-haloalquilen-tetrazol de aplicacion exclusiva como reactivo en dicho procedimiento | |
ES490110A0 (es) | Procedimiento de preparar aril-3 ester-5 oxazolidinonas-2 y oxazolidinationas-2 nuevas | |
AR226284A1 (es) | Composicion de catalizador y procedimiento para prepararla | |
AR225744A1 (es) | Un procedimiento para la preparacion de derivados n-substituidos de 3-feniluropilamina y derivados aplicados como intermediarios en dicho procedimiento | |
AR231971A1 (es) | Procedimiento para preparar n-1(s)-etoxicarbonil(o carboxi)-3-fenilpropil-l-alanil-l-prolinas utiles como antihipertensivos | |
AR219150A1 (es) | Procedimiento para preparar nuevos derivados de aminoazucares | |
ES496714A0 (es) | Procedimiento para preparar alfa-aril-1h-1,2,4-triazol-1- etanoles | |
AR222481A1 (es) | Procedimiento para obtener derivados de 1-(omega-alcanoiltio o omega-mercaptoalconoil)3,4-deshidroprolina | |
ES489628A0 (es) | Procedimiento para la obtencion de derivados de tetrahidro- piridina y piperidina | |
AR227761A1 (es) | Nuevos compuestos de urea y tiourea,metodos de preparacion de los mismos,composicion insecticida que los contiene y su metodo de preparacion | |
AR219789A1 (es) | Procedimiento para preparar eiclohexanol y ciclohexanona por oxidacion | |
ES485399A0 (es) | Procedimiento para preparar pastillas de glucosidos cardioactivos | |
AR225143A1 (es) | Procedimiento para preparar derivados de fenil-metil-hidantoina | |
AR230059A1 (es) | Procedimiento para obtener derivados de piperidil-1-il-alcoxi o hidroxialcoxi-carboestirilo o 3,4-dihidrocarboestirilo | |
AR222846A1 (es) | Procedimiento para la obtencion de 2,3,5-tricloropiridina | |
EG13793A (en) | Stilbene derivatives,processes for their preparation and their use as insecticides | |
AR231638A1 (es) | Procedimiento para obtener compuestos de 1-1-2-(1,4-benzoxatio o 1,4-benzoxatian o 1,4-benzodioxan-2-il)-alquilen-4-piperidil-2-imidazolinona,2-hexahidro-pirimidinona o 2-imino-imidazolidina | |
AR218563A1 (es) | Procedimiento para preparar urea | |
ES251117Y (es) | Pasador para arboles,ejes y similares | |
AR220383A1 (es) | Procedimiento para la preparacion de 2,3,5,6-tetracloropiridina y pentacloropiridina | |
MX6217E (es) | Procedimiento para la preparacion de 4,1-benzoxazepinas y 4,1-benzotiazepinas | |
BE873906A (fr) | Derives de phenyluree, leur procede de preparation ainsi que leur utilisation | |
BR7903620A (pt) | Processo para a preparacao de piridinaldeidos e derivados processo para a preparacao de piridinaldeidos e derivados destes destes | |
AR228020A1 (es) | Procedimiento para preparar derivados de 2-benciliden-benzofuran-3-ona | |
AR219780A1 (es) | Nuevos derivados de 3,4-metano-pirrolidina y procedimiento para su preparacion |